Matches in Wikidata for { <http://www.wikidata.org/entity/Q92050309> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q92050309 description "artículu científicu espublizáu en mayu de 2019" @default.
- Q92050309 description "scientific article published on 01 May 2019" @default.
- Q92050309 description "wetenschappelijk artikel" @default.
- Q92050309 description "наукова стаття, опублікована 1 травня 2019" @default.
- Q92050309 name "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 name "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 type Item @default.
- Q92050309 label "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 label "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 prefLabel "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 prefLabel "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 P1433 Q92050309-213AAEB9-34D8-437B-9503-9C38E8F3B9B9 @default.
- Q92050309 P1476 Q92050309-28C0FDC7-398B-42DE-ADB4-5E554EE124EF @default.
- Q92050309 P2093 Q92050309-1EC02D21-E678-4A2A-971C-7529EFC6676E @default.
- Q92050309 P2093 Q92050309-2BFEE311-F919-41F3-B986-A707B1AEC08D @default.
- Q92050309 P2093 Q92050309-3BC3A81B-68F7-4303-BAD7-B9E3885C2701 @default.
- Q92050309 P2093 Q92050309-4A9ABE0C-F89F-41A8-8A1A-717CC7D015BC @default.
- Q92050309 P2093 Q92050309-7F470F3B-BB7D-454B-94A6-E481F68BE3B0 @default.
- Q92050309 P2093 Q92050309-D1FAD2E8-4AB1-4EE0-B757-5073B8286C26 @default.
- Q92050309 P2093 Q92050309-E444DBCE-A81E-48FB-922B-D71C3BB9EEB0 @default.
- Q92050309 P2093 Q92050309-FD34158F-CCD2-4649-9B28-548C82383031 @default.
- Q92050309 P304 Q92050309-845D5EDB-4CC7-41F6-9D1A-E1F2D70395B0 @default.
- Q92050309 P31 Q92050309-09CC0C80-66C4-4D3C-AB25-73411C617B53 @default.
- Q92050309 P356 Q92050309-72ECE40D-43A6-4159-A0F2-963EC89D95C2 @default.
- Q92050309 P433 Q92050309-EE534598-9B79-4970-B85C-5F8C8BEAC164 @default.
- Q92050309 P478 Q92050309-CA6CC31F-A847-42FD-B963-7592541A24DC @default.
- Q92050309 P50 Q92050309-810D7CF6-25A0-4B91-8B1A-5150F87F0DBA @default.
- Q92050309 P577 Q92050309-6B132D74-B971-4909-B1CB-94CAC23E5A4E @default.
- Q92050309 P698 Q92050309-0E305D4E-167B-48E4-AF7B-96C24170A220 @default.
- Q92050309 P921 Q92050309-BD7D67C8-61B0-4F2A-9DBC-11D1F3F9B120 @default.
- Q92050309 P356 1078-0432.CCR-19-1098 @default.
- Q92050309 P698 31092617 @default.
- Q92050309 P1433 Q332253 @default.
- Q92050309 P1476 "Correction: Efficacy and Safety of the Biosimilar ABP 215 Compared with Bevacizumab in Patients with Advanced Nonsquamous Non-small Cell Lung Cancer (MAPLE): A Randomized, Double-blind, Phase III Study" @default.
- Q92050309 P2093 "Gyula Ostoros" @default.
- Q92050309 P2093 "Jerome H Goldschmidt" @default.
- Q92050309 P2093 "Luis Paz-Ares Rodriguez" @default.
- Q92050309 P2093 "Michael Schenker" @default.
- Q92050309 P2093 "Michael Thomas" @default.
- Q92050309 P2093 "Nicholas Thatcher" @default.
- Q92050309 P2093 "Vladimir Hanes" @default.
- Q92050309 P2093 "Zhiying Pan" @default.
- Q92050309 P304 "3193" @default.
- Q92050309 P31 Q13442814 @default.
- Q92050309 P356 "10.1158/1078-0432.CCR-19-1098" @default.
- Q92050309 P433 "10" @default.
- Q92050309 P478 "25" @default.
- Q92050309 P50 Q77664479 @default.
- Q92050309 P577 "2019-05-01T00:00:00Z" @default.
- Q92050309 P698 "31092617" @default.
- Q92050309 P921 Q413299 @default.